Biosecure Act appears headed for final passage in defense billnews2025-12-08T20:17:06+00:00December 8th, 2025|Endpoints News|
Trump administration pushes end-of-term deadline for ‘most favored nation’ promisesnews2025-12-04T16:10:15+00:00December 4th, 2025|Endpoints News|
BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand news2025-12-04T15:01:36+00:00December 4th, 2025|Endpoints News|
Excelsior Sciences raises $95M for small molecule drug discovery, manufacturingnews2025-12-03T13:00:11+00:00December 3rd, 2025|Endpoints News|
Pentagon seeks to add WuXi AppTec to military list: reportnews2025-12-02T20:19:07+00:00December 2nd, 2025|Endpoints News|
Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDAnews2025-12-02T11:30:10+00:00December 2nd, 2025|Endpoints News|
UK to spend more on medicines for US tariff exemptionnews2025-12-01T16:28:20+00:00December 1st, 2025|Endpoints News|
Novartis plans to lay off 550 workers at Swiss factory news2025-11-25T14:18:48+00:00November 25th, 2025|Endpoints News|
AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the USnews2025-11-21T19:33:41+00:00November 21st, 2025|Endpoints News|
Pentagon-backed Lumen is ready to drastically slash antibody manufacturing costsnews2025-11-20T20:46:37+00:00November 20th, 2025|Endpoints News|
